Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
NASDAQ:XENT
Price:
28.24 USD
Market Closed
Updated:
May 3, 2024
Intersect Ent Inc
Revenue
|
Intersect Ent Inc
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Intersect Ent Inc
NASDAQ:XENT
|
Revenue
$104m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Intersect Ent Inc
Revenue Breakdown
Breakdown by Geography
Intersect Ent Inc
Intersect Ent Inc
Not Available
Breakdown by Segments
Intersect Ent Inc
Intersect Ent Inc
|
Total Revenue:
106.8m
USD
|
|
Propel Family Of Products:
91.1m
USD
|
|
Sinuva:
9.1m
USD
|
|
Vensure, Cube, And Accessories:
6.6m
USD
|
See Also
What is Intersect Ent Inc's Revenue?
Revenue
104m
USD
104m
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Revenue amounts to 104m USD.
What is Intersect Ent Inc's Revenue growth rate?
Revenue CAGR 5Y
5%
5%
Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Intersect Ent Inc have been -2% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
